A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
Status:
Completed
Trial end date:
2007-07-06
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of romosozumab
following single dose subcutaneous (SC) or intravenous (IV) administration in healthy men and
postmenopausal women.